India: Life Sciences, Biotechnology & Nanotechnology

Can a pharmaceutical giant's two-decade-old brand name ‘A TO Z' command exclusive rights over those three terms in the multivitamin market? And what happens when a smaller competitor enters with a composite mark containing the same alphabetical endpoints, embedded within an entirely different word?

For years, the medical device industry has operated in a regulatory tug-of-war caught between the labelling requirements of the Legal Metrology (Packaged Commodities) Rules, 2011 & amendments thereof (“LM Rules”) and Medical Devices Rules, 2017 (“MD Rules”).

India's life sciences and healthcare sector saw significant regulatory shifts in April 2026, including proposed decriminalization of minor violations, new medical device testing fees, and streamlined foreign training requirements for healthcare professionals. Courts also delivered key rulings on pharmaceutical trademark disputes, reinforcing stricter standards for drug name similarity.

On 29 June 2025,1 Torrent Pharmaceuticals Limited("Torrent") announced a strategic transaction to acquire a controlling stake in J.B. Chemicals & Pharmaceuticals Limited("JB Pharma"), followed by the proposed...

Welcome to the December 2025 edition of our Life Sciences and Healthcare Newsletter, covering key regulatory, policy, and industry developments across the sector.

In the past couple of months, India's healthcare and pharmaceutical sectors have seen a continued push towards regulatory strengthening, quality standardisation, and innovation-driven growth.

To strengthen the technical evaluation process that supports regulatory decisions and to bring formal structure to the functioning of Subject Expert Committees (SECs)...

The Kerala High Court has set a precedent in the case of Uvais Muhammad K.C. & Another v. State of Kerala & Others, emphasizing that genuine altruistic...

The Ministry of Consumer Affairs, Food and Public Distribution has notified the Legal Metrology (General) Third Amendment Rules, 2025...